News & Analysis on Clinical Trial Services & Contract Research And Development
The international team of scientists working to determine the most common variations of the human genome have given more details of the rationale behind the effort, known as the HapMap project, in the journal Nature (18 December).
A UK-based animal rights group has passed video footage of alleged animal cruelty at a facility in Germany run by US contract research company Covance to the Ministry of Environment in Northrhine-Westfalia.
2003 was the second best year of all time for the biotechnology industry, and 2004 looks set to be even better. This is the verdict of James Burrill, head of US merchant bank Burrill & Co, who describes the industry as "rising like a phoenix from the...
Formulation specialist TransForm Pharmaceuticals has licensed a novel salt form of the antiepileptic drug topiramate to Johnson & Johnson in a development that provides the first real validation of its business model.
Kiadis of the Netherlands has acquired the entire issued share capital and assets of Selact in a move that bolsters its capabilities in chemical synthesis and contract research.
US packaging giant MeadWestvaco has started the second phase of a restructuring programme aimed at improving productivity at the firm and boosting both earnings and cash flow, at the cost of 1,000 job cuts and a number of facility closures.
The restructuring activity that has features this year in the European pharmachem industry continued yesterday with the news that Germany's Merck KGaA had sold off BioMer, a joint venture focusing on orthopaedic products.